Global Enalapril Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Enalapril Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Enalapril is used to treat hypertension, symptomatic heart failure, and asymptomatic left ventricular dysfunction.[9] It has been proven to protect the function of the kidneys in hypertension, heart failure, and diabetes, and may be used in the absence of hypertension for its kidney protective effects.[10] It is widely used in chronic kidney failure.[11] Furthermore, enalapril is an emerging treatment for psychogenic polydipsia.
Enalapril report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Enalapril market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Drugs Store are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Enalapril industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Enalapril key manufacturers include Apotex Inc, Apothecon Inc Div Bristol Myers Squibb, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Krka Dd Novo Mesto, Lek Pharmaceuticals D D, Mylan Pharmaceuticals Inc, Ranbaxy Laboratories Ltd, Sandoz Inc and Taro Pharmaceutical Industries Ltd, etc. Apotex Inc, Apothecon Inc Div Bristol Myers Squibb, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa are top 3 players and held % sales share in total in 2022.
Enalapril can be divided into 2.5mg, 5mg, 10mg and 20mg, etc. 2.5mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Enalapril is widely used in various fields, such as Hospital and Drugs Store, etc. Hospital provides greatest supports to the Enalapril industry development. In 2022, global % sales of Enalapril went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Enalapril market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Apotex Inc
Apothecon Inc Div Bristol Myers Squibb
Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
Krka Dd Novo Mesto
Lek Pharmaceuticals D D
Mylan Pharmaceuticals Inc
Ranbaxy Laboratories Ltd
Sandoz Inc
Taro Pharmaceutical Industries Ltd
Teva Pharmaceuticals Usa Inc
Watson Laboratories Inc
Wockhardt Americas Inc
Biovail Laboratories International Srl
Bedford Laboratories Div Ben Venue Laboratories Inc
Hikma Farmaceutica (Portugal) Sa
Hospira Inc
Teva Parenteral Medicines Inc
Segment by Type
2.5mg
5mg
10mg
20mg
Hospital
Drugs Store
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Enalapril market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Enalapril, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Enalapril industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Enalapril in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Enalapril introduction, etc. Enalapril Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Enalapril market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Enalapril report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Enalapril market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Drugs Store are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Enalapril industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Enalapril key manufacturers include Apotex Inc, Apothecon Inc Div Bristol Myers Squibb, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Krka Dd Novo Mesto, Lek Pharmaceuticals D D, Mylan Pharmaceuticals Inc, Ranbaxy Laboratories Ltd, Sandoz Inc and Taro Pharmaceutical Industries Ltd, etc. Apotex Inc, Apothecon Inc Div Bristol Myers Squibb, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa are top 3 players and held % sales share in total in 2022.
Enalapril can be divided into 2.5mg, 5mg, 10mg and 20mg, etc. 2.5mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Enalapril is widely used in various fields, such as Hospital and Drugs Store, etc. Hospital provides greatest supports to the Enalapril industry development. In 2022, global % sales of Enalapril went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Enalapril market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Apotex Inc
Apothecon Inc Div Bristol Myers Squibb
Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
Krka Dd Novo Mesto
Lek Pharmaceuticals D D
Mylan Pharmaceuticals Inc
Ranbaxy Laboratories Ltd
Sandoz Inc
Taro Pharmaceutical Industries Ltd
Teva Pharmaceuticals Usa Inc
Watson Laboratories Inc
Wockhardt Americas Inc
Biovail Laboratories International Srl
Bedford Laboratories Div Ben Venue Laboratories Inc
Hikma Farmaceutica (Portugal) Sa
Hospira Inc
Teva Parenteral Medicines Inc
Segment by Type
2.5mg
5mg
10mg
20mg
Segment by Application
Hospital
Drugs Store
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Enalapril market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Enalapril, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Enalapril industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Enalapril in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Enalapril introduction, etc. Enalapril Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Enalapril market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.